• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Low-Fat Diet Helps Prevent Breast Cancer Relapse


SAN ANTONIO -- A diet with 20% of calories from fat, or less, may help reduce risk of breast cancer recurrence, particularly for women with hormone-receptor negative disease, according to a large trial.

SAN ANTONIO, Dec. 16 -- A diet with 20% of calories from fat, or less, may help reduce risk of breast cancer recurrence, particularly for women with hormone-receptor-negative disease, according to a large trial.

Among more than 2,400 women with early breast cancer followed for 5.8 years, there were 22% fewer deaths for those on the low-fat diet, although this difference was not significant, said Rowan T. Chlebowski, M.D., Ph.D., of Harbor-UCLA Medical Center in Torrance, Calif. But it was significant for a subset with estrogen-receptor-negative disease.

The randomized, prospective trial comparing a low-fat diet with a normal diet was presented at the San Antonio Breast Cancer Symposium and published simultaneously in the Journal of the National Cancer Institute.

The researchers reported a borderline significant improvement in relapse-free survival (hazard ratio 0.76, 95% confidence interval 0.60 to 0.98) and a nonsignificant benefit in overall survival (HR 0.89, 95% CI 0.65 to 1.21).

However, for the 362 women with estrogen- and progesterone-receptor-negative breast cancer, there was a 66% reduction in mortality for an 11% absolute survival advantage in the diet group (HR 0.47, 95% CI 0.29 to 0.78, P=0.001).

This benefit for hormone receptor negative cancers is as great as has been seen with any other treatment for this notoriously difficult to treat cancer type, said session moderator Richard Elledge, M.D., of Baylor College in Houston.

"This is a seminal study," he said. "They have fewer treatment options."

The National Cancer Institute-sponsored study randomized 975 women to a dietary intervention with the goal of reducing dietary fat to 15% of total calories. They attended eight biweekly, one-hour counseling sessions to learn about the low-fat eating plan, kept written records of their daily fat gram intake, met with or talked to dietitians every three months, and could attend optional monthly group sessions. The 1,462 women in the control group met with a dietitian when they started the trial and were called by dietitians every three months.

All patients (mean age about 58) had early-stage breast cancer for which they underwent surgery and systemic therapy (tamoxifen for estrogen-receptor positive and chemotherapy for estrogen-receptor negative tumors). Radiation therapy was optional as was chemotherapy for estrogen-receptor-positive disease.

Though both groups started with a daily fat intake of about 56 to 57 grams (about 30% of total calories), the diet group dropped to an average of 33 grams per day (20.3% of total calories) while the control group stayed at 51 g/day (29.2% of total calories) at one year, which was sustained through the trial.

As might be expected, women in the intervention group lost an average of 1.1 kg/m2 in body mass index and an average of 6.0 pounds more than those in the control group over five years (both P

Dr. Kipnis and colleagues also warned oncologists that the effects of weight loss and dietary fat reduction are difficult to disentangle.

"The relation between dietary fat and breast cancer incidence and survival remains one of the most controversial hypotheses in nutritional epidemiology, with mostly observational studies showing rather inconsistent results," they added.

The study authors acknowledged that findings could have been confounded by the higher frequency of mastectomy in the diet group compared to the control group, but said adjusting for this did not eliminate the diet's advantage. Also, the study's funding ended before the full three years of planned post-intervention follow-up, which may have impacted data recovery, they said.

The researchers concluded that dietary fat reduction may be appropriate for some highly motivated women, but that the diet may be difficult for women to sustain without the assistance of a dietician or other support.

Dr. Elledge pointed out that there is little reason not to recommend such a diet for women who ask what else they can do to prevent breast cancer relapse. "It's good for other diseases as well," he said.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Overweight and Obesity: One Expert's 3 Wishes for the Future of Patient Care
Donna H Ryan, MD Obesity Expert Highlights 2021 Research Success and Looks to 2022 and Beyond
"Obesity is a Medically Approachable Problem" and Other Lessons with Lee Kaplan, MD, PhD
Related Content
© 2024 MJH Life Sciences

All rights reserved.